Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus.

Madsen KS, Kähler P, Kähler LKA, Madsbad S, Gnesin F, Metzendorf MI, Richter B, Hemmingsen B.

Cochrane Database Syst Rev. 2019 Apr 18;4:CD012368. doi: 10.1002/14651858.CD012368.pub2.

PMID:
30998259
2.

Analogue insulin as an essential medicine: the need for more evidence and lower prices.

Beran D, Hemmingsen B, Yudkin JS.

Lancet Diabetes Endocrinol. 2019 May;7(5):338. doi: 10.1016/S2213-8587(19)30111-1. Epub 2019 Mar 22. No abstract available.

PMID:
30910501
3.

Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Ponce OJ, Larrea-Mantilla L, Hemmingsen B, Serrano V, Rodriguez-Gutierrez R, Spencer-Bonilla G, Alvarez-Villalobos N, Benkhadra K, Haddad A, Gionfriddo MR, Prokop LJ, Brito JP, Murad MH.

J Clin Endocrinol Metab. 2019 May 1;104(5):1585-1594. doi: 10.1210/jc.2019-00195.

PMID:
30903687
4.

Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Richter B, Hemmingsen B, Metzendorf MI, Takwoingi Y.

Cochrane Database Syst Rev. 2018 Oct 29;10:CD012661. doi: 10.1002/14651858.CD012661.pub2.

PMID:
30371961
5.

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.

Nordklint AK, Almdal TP, Vestergaard P, Lundby-Christensen L, Boesgaard TW, Breum L, Gade-Rasmussen B, Sneppen SB, Gluud C, Hemmingsen B, Jensen T, Krarup T, Madsbad S, Mathiesen ER, Perrild H, Tarnow L, Thorsteinsson B, Vestergaard H, Lund SS, Eiken P.

Osteoporos Int. 2018 Nov;29(11):2517-2526. doi: 10.1007/s00198-018-4637-z. Epub 2018 Jul 19.

PMID:
30027438
6.

Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B.

Cochrane Database Syst Rev. 2017 Dec 4;12:CD003054. doi: 10.1002/14651858.CD003054.pub4. Review.

7.

Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135.

Sonne DP, Hemmingsen B.

Diabetes Care. 2017 Jul;40(7):e92-e93. doi: 10.2337/dc17-0299. No abstract available.

PMID:
28637892
9.
10.

Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus.

Hemmingsen B, Krogh J, Metzendorf MI, Richter B.

Cochrane Database Syst Rev. 2016 Apr 21;4:CD012106. doi: 10.1002/14651858.CD012106.pub2. Review.

11.

Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Lundby-Christensen L, Vaag A, Tarnow L, Almdal TP, Lund SS, Wetterslev J, Gluud C, Boesgaard TW, Wiinberg N, Perrild H, Krarup T, Snorgaard O, Gade-Rasmussen B, Thorsteinsson B, Røder M, Mathiesen ER, Jensen T, Vestergaard H, Hedetoft C, Breum L, Duun E, Sneppen SB, Pedersen O, Hemmingsen B, Carstensen B, Madsbad S.

BMJ Open. 2016 Feb 25;6(2):e008377. doi: 10.1136/bmjopen-2015-008377.

12.

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Lundby-Christensen L, Tarnow L, Boesgaard TW, Lund SS, Wiinberg N, Perrild H, Krarup T, Snorgaard O, Gade-Rasmussen B, Thorsteinsson B, Røder M, Mathiesen ER, Jensen T, Vestergaard H, Hedetoft C, Breum L, Duun E, Sneppen SB, Pedersen O, Hemmingsen B, Carstensen B, Madsbad S, Gluud C, Wetterslev J, Vaag A, Almdal TP.

BMJ Open. 2016 Feb 25;6(2):e008376. doi: 10.1136/bmjopen-2015-008376.

13.

WITHDRAWN: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal TP.

Cochrane Database Syst Rev. 2015 Jul 29;(7):CD009008. doi: 10.1002/14651858.CD009008.pub3. No abstract available.

PMID:
26222249
14.

WITHDRAWN: Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Wetterslev J.

Cochrane Database Syst Rev. 2015 Jul 29;(7):CD008143. doi: 10.1002/14651858.CD008143.pub4. No abstract available.

PMID:
26222248
15.

Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis.

Hemmingsen B, Schroll JB, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

CMAJ Open. 2014 Jul 22;2(3):E162-75. doi: 10.9778/cmajo.20130073. eCollection 2014 Jul.

16.

Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Kähler P, Grevstad B, Almdal T, Gluud C, Wetterslev J, Lund SS, Vaag A, Hemmingsen B.

BMJ Open. 2014 Aug 19;4(8):e004806. doi: 10.1136/bmjopen-2014-004806. Review. Erratum in: BMJ Open. 2015;5(6):e004806corr1. Lund, Søren Søgaard [added].

17.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD008143.

PMID:
24214280
18.

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD009008.

PMID:
23633364
19.

Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses.

Hemmingsen B, Christensen LL, Wetterslev J, Vaag A, Gluud C, Lund SS, Almdal T.

BMJ. 2012 Apr 19;344:e1771. doi: 10.1136/bmj.e1771. Review.

PMID:
22517929
20.

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J.

BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898. Review.

Supplemental Content

Loading ...
Support Center